Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
or
Menu

Enteromedics Inc (ETRM)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (BATS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ fieldTitles[key] ]] [[ value ]] [[ value ]]
[[ ctrl.chartTitle ]]
Full Chart

Fundamentals

See More
  • Market Capitalization, $K 28,923
  • Shares Outstanding, K 6,870
  • Annual Sales, $ 790 K
  • Annual Income, $ -23,360 K
  • 36-Month Beta 2.24
  • Price/Sales 37.91
  • Price/Cash Flow 0.00
  • Price/Book 4.05

Price Performance

See More
Period Period Low Period High Performance
1-Month
4.00 +5.00%
on 04/25/17
6.48 -35.19%
on 04/06/17
-1.45 (-25.66%)
since 03/28/17
3-Month
4.00 +5.00%
on 04/25/17
8.59 -51.11%
on 02/02/17
-2.76 (-39.66%)
since 01/27/17
52-Week
1.75 +140.00%
on 01/04/17
63.00 -93.33%
on 05/02/16
-54.60 (-92.86%)
since 04/28/16

Most Recent Stories

More News
Medical Equipment Stocks on Investors' Radar -- Abbott, Boston Scientific, Medtronic, and EnteroMedics

Stock-Callers.com revisits the Medical Appliances and Equipment industry, which includes companies that are engaged in the manufacture of medical instruments such as dental and surgical appliances. For...

ABT : 43.64 (-0.02%)
BSX : 26.38 (+0.76%)
ETRM : 4.20 (-0.24%)
MDT : 83.09 (-0.05%)
EnteroMedics' vBloc® Neurometabolic Therapy Recognized at 2017 Edison Awards

EnteroMedics Inc. (NASDAQ:ETRM), the developer of medical devices using neuroblocking technology to treat obesity, metabolic diseases and other gastrointestinal disorders, today announced it has been named...

ETRM : 4.20 (-0.24%)
Technical Reports on Medical Equipment Stocks -- EnteroMedics, Abbott Labs, Boston Scientific, and Medtronic

Today at Stock-Callers.com, investors' attention is directed to four equities in the Medical Appliances and Equipment space, and they are: EnteroMedics Inc. (NASDAQ: ETRM), Abbott Laboratories (NYSE: ABT),...

ABT : 43.64 (-0.02%)
BSX : 26.38 (+0.76%)
ETRM : 4.20 (-0.24%)
MDT : 83.09 (-0.05%)
Here's Why EnteroMedics (ETRM) Stock Soared Today

Shares of EnteroMedics (ETRM) were up more than 10% in morning trading Tuesday after it was confirmed that the medical device company's new neuro-blocking obesity treatment will be featured on the daytime...

ETRM : 4.20 (-0.24%)
EnteroMedics Regains Compliance With Nasdaq Listing Requirement

EnteroMedics Inc. (NASDAQ:ETRM), the developer of medical devices using neuroblocking technology to treat obesity, metabolic diseases and other gastrointestinal disorders, today announced that on February...

ETRM : 4.20 (-0.24%)
EnteroMedics Announces Closing of $19.0 Million Underwritten Public Offering and Full Exercise of Over-allotment Option

EnteroMedics Inc. (NASDAQ: ETRM), the developer of medical devices using neuroblocking technology to treat obesity, metabolic diseases and other gastrointestinal disorders, announced the closing of an...

LTS : 2.78 (+2.96%)
ETRM : 4.20 (-0.24%)
EnteroMedics Announces Pricing of $16.5 Million Underwritten Public Offering

EnteroMedics Inc. (NASDAQ:ETRM), the developer of medical devices using neuroblocking technology to treat obesity, metabolic diseases and other gastrointestinal disorders, today announced the pricing of...

LTS : 2.78 (+2.96%)
ETRM : 4.20 (-0.24%)
Stock Market Roundup, Jan. 10: NVDA Self-Driving Cars, ETRM Soars

Stocks continued their relatively solid start to the New Year with another positive day of trading on Tuesday. Perhaps the biggest newsmakers on the day were NVIDIA and Mercedes-Benz, as the pair announced...

DDAIF : 74.4201 (+0.31%)
ZEUS : 22.55 (+17.26%)
NVDA : 104.30 (-1.27%)
HIIQ : 16.75 (+4.36%)
ETRM : 4.20 (-0.24%)
VALE : 8.58 (+1.90%)
EnteroMedics Announces Retirement of All Senior Convertible Notes

EnteroMedics Inc. (NASDAQ:ETRM), the developer of medical devices using neuroblocking technology to treat obesity, metabolic diseases and other gastrointestinal disorders, today announced that as of Tuesday,...

ETRM : 4.20 (-0.24%)
Blog Coverage EnteroMedics Announced 1-for-70 Reverse Stock Split and Amortization of its Convertible Notes

Upcoming AWS Coverage on ViewRay, Inc. Post-Earnings Results

ETRM : 4.20 (-0.24%)
VRAY : 6.90 (+4.86%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 96% Sell with a Strengthening short term outlook on maintaining the current direction.

Longer term, the trend strength is Average. Long term indicators fully support a continuation of the trend.

The market is approaching oversold territory. Be watchful of a trend reversal.

See More

Business Summary

EnteroMedics Inc. was established to develop and commercialize a new therapeutic platform for treating a wide range of acute and chronic diseases that are mediated by the vagal nerves. Due to the large unmet need for more effective surgical management of obesity, and following an in-depth analysis of...

See More

Support & Resistance

2nd Resistance Point 4.33
1st Resistance Point 4.27
Last Price 4.20
1st Support Level 4.11
2nd Support Level 4.01

See More

Add Data Columns to this Table
Learn about our Custom Views
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.